Analyst Expectations For 4D Molecular Therapeutics's Future
Analyst Expectations For 4D Molecular Therapeutics's Future
分析师对4d molecular therapeutics未来的预期
A comprehensive examination of how financial experts perceive...In the preceding three months, 4 analysts have released ratings for 4D Molecular Therapeutics (NASDAQ:FDMT), presenting a wide array of perspectives from bullish to bearish.
在过去三个月中，4位分析师发布了对4d molecular therapeutics（纳斯达克:FDMT）的评级，展现了从看好到看淡的广泛观点。
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
下表总结了他们最近的评级，展示了过去30天内不断变化的情绪，并将其与前几个月进行了比较。
The 12-month price targets, analyzed by analysts, offer insights with an average target of $37.5, a high estimate of $39.00, and a low estimate of $36.00. A 2.6% drop is evident in the current average compared to the previous average price target of $38.50.
由分析师分析的12个月价格目标提供了洞察，平均目标为37.5美元，最高估计为39.00美元，最低估计为36.00美元。与之前的平均价格目标38.50美元相比，目前的平均目标明显下降了2.6%。
Deciphering Analyst Ratings: An In-Depth Analysis
分析师评级解读：深入分析
A comprehensive examination of how financial experts perceive...
对金融专家如何看...
登录免费看全文
登录/注册
资讯热榜
更新时间